These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29625336)

  • 21. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
    Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
    Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
    Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
    Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease.
    Qi Y; Gong F; Zhang Q; Xie C; Wang W; Fu S
    Arthritis Res Ther; 2012 Nov; 14(6):R251. PubMed ID: 23171632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.
    Luo L; Feng S; Wu Y; Su Y; Jing F; Yi Q
    Pediatr Infect Dis J; 2019 Jan; 38(1):89-94. PubMed ID: 29601451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
    Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
    Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Clin Rheumatol; 2022 Jan; 41(1):137-145. PubMed ID: 34363547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL; Wang JL; Li WQ
    Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease.
    Weng KP; Hsieh KS; Hwang YT; Huang SH; Lai TJ; Yuh YS; Hou YY; Lin CC; Huang SC; Chang CK; Lin MW; Ger LP
    Circ J; 2010 May; 74(5):983-9. PubMed ID: 20339193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
    Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
    Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T; Suzuki Y; Hasegawa S; Matsushige T; Kusuda T; Hoshide M; Takahashi K; Okada S; Wakiguchi H; Moriwake T; Uchida M; Ohbuchi N; Iwai T; Hasegawa M; Ichihara K; Yashiro M; Makino N; Nakamura Y; Ohga S
    Int J Cardiol; 2016 Jul; 214():209-15. PubMed ID: 27070994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.
    Hachiya A; Kobayashi N; Matsuzaki S; Takeuchi Y; Akazawa Y; Shigemura T; Motoki N; Masumoto J; Agematsu K
    Clin Rheumatol; 2018 Jul; 37(7):1937-1943. PubMed ID: 29302828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-31 associated with coronary artery lesion formation in Kawasaki disease.
    Tseng WN; Lo MH; Guo MM; Hsieh KS; Chang WC; Kuo HC
    PLoS One; 2014; 9(8):e105195. PubMed ID: 25122210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.